Chen Piller is a Subject Matter Expert in the Biology Group at BTG A Ferring Company since May 2024, specializing in plate-based and cell-based analytical methods. Prior to this role, Chen served as a Scientist in Assay Development at BiomX Inc, focusing on microbiology and molecular activities related to phage-based therapy. Chen also led collaborative research on epitope-based vaccines at Ramot, Tel Aviv University's Tech Transfer Company, and taught undergraduate biology courses at Tel Aviv University while contributing as a research assistant. Chen's career includes experience in preclinical research at Envigo and laboratory management at Ben-Gurion University. Educational qualifications include a Ph.D. in Cell Research and Immunology and a Master's in Marine Biology and Ecotoxicology, alongside a visiting researcher role at the University of Toronto's Recombinant Antibody Centre.
This person is not in the org chart